{"title":"Onconephrology Fellowship Training: Current Status and Future Outlook.","authors":"Macro Bonilla, Abdallah S Geara","doi":"10.34067/KID.0000000000000495","DOIUrl":null,"url":null,"abstract":"<p><p>Onconephrology, an emerging discipline nestled at the intersection of nephrology and oncology, has experienced remarkable growth over the past 15 years. This evolution has been punctuated by pivotal events, including establishing the American Society of Onconephrology, dedicated forums, and journals, highlighting its increasing significance. The clinical landscape of onconephrology is diverse, encompassing AKI in patients with cancer, toxicity from anticancer treatments, and a spectrum of electrolyte disorders, necessitating close collaboration between nephrologists and oncologists. However, trainees and mentors encounter various challenges surrounding its status as a distinct subspecialty. To overcome these barriers, there is a pressing need for streamlined training pathways, enhanced interdisciplinary collaboration, and targeted research efforts to elucidate the effect of onconephrology on patient outcomes. By addressing these challenges head-on, the field of onconephrology can continue its trajectory of growth and better serve patients with cancer with complex kidney needs.</p>","PeriodicalId":17882,"journal":{"name":"Kidney360","volume":null,"pages":null},"PeriodicalIF":3.2000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11441803/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kidney360","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.34067/KID.0000000000000495","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Onconephrology, an emerging discipline nestled at the intersection of nephrology and oncology, has experienced remarkable growth over the past 15 years. This evolution has been punctuated by pivotal events, including establishing the American Society of Onconephrology, dedicated forums, and journals, highlighting its increasing significance. The clinical landscape of onconephrology is diverse, encompassing AKI in patients with cancer, toxicity from anticancer treatments, and a spectrum of electrolyte disorders, necessitating close collaboration between nephrologists and oncologists. However, trainees and mentors encounter various challenges surrounding its status as a distinct subspecialty. To overcome these barriers, there is a pressing need for streamlined training pathways, enhanced interdisciplinary collaboration, and targeted research efforts to elucidate the effect of onconephrology on patient outcomes. By addressing these challenges head-on, the field of onconephrology can continue its trajectory of growth and better serve patients with cancer with complex kidney needs.